Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Crossover Trial to Investigate the Efficacy of Treatments in Apomorphine-induced Skin Reactions

NCT02230930 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02230930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02230930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Crossover Trial to Investigate the Efficacy of Treatments in Apomorphine-induced Skin Reactions
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2015
Completion date
December 31, 2018
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apomorphine-induced skin reactions, parkinson's disease